DaVita Inc. DVA
Verdict: Hold. Fair value $138 against a price of $114 on 6 Jan 2026, 21% above the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Net Income has shown significant volatility, dropping 43% in 2022 (from $0.98B to $0.56B) before....
Main risks
- Extreme Leverage: The Debt-to-Equity ratio exceeds 100, indicating a precarious capital structure almost entirely financed by debt. The equity base is virtually non-existent, offering no cushion against operational or financial shocks.
- Negative Incremental Returns on Capital: The calculated 3-year ROIIC is -0.5%, suggesting that capital invested over the period has failed to generate positive returns, effectively destroying value. This raises serious questions about management's capital allocation strategy.
- Sluggish Revenue Growth: A 3-year revenue CAGR of 3.3% is low, barely keeping pace with inflation. This slow growth may be insufficient to service the company's massive debt load over the long term, especially in a rising interest rate environment.
- Overhang: The primary overhang is the 23% year-to-date share price decline, which has led to a 'reas...
- Technical signals bearish (strong sell)
- Market volatility